The weekly litigation news digest is live. Subscribe now
Compositions Of Human Prothrombin And Activated Factor X For Improving Hemostasis In The Treatment Of Bleeding Disorders - EP3116534
The patent EP3116534 was granted to Baxalta on May 29, 2019. The application was originally filed on Mar 13, 2015 under application number EP15712018A. The patent is currently recorded with a legal status of "Revoked".
EP3116534
- Application Number
- EP15712018A
- Filing Date
- Mar 13, 2015
- Status
- Revoked
- Nov 6, 2020
- Publication Date
- May 29, 2019
- External Links
- Slate, Register, Google Patents
Patent Summary
Patent Family
Patent Oppositions
Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
Patent Citations (1) New
Patent citations refer to prior patents cited during different phases such as opposition or international search.
Dossier Documents
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents